Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Backers
1
M Ventures
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
3T BiosciencesFounded 2017 • 51-200 employees
We are solving a major bottleneck in the field of targeted biotherapeutics in oncology – the identification of novel targets for the…
CytosolixVenture round $6.6M · 3 yr ago • 11-50 employees
Our Tumor Activated Permeability (TAP) Platform produces weakly-acidic derivatives of known oncology drugs that already work. It preserves…
OncosenxVenture round $650k · 5 yr ago • Founded 2017 • 11-50 employees
The Next Generation in. OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid…
AlixiaVenture round $1.8M · 2 yr ago • Founded 2022
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.
OutpacebioVenture round $56M · 2 yr ago • Founded 2020 • 51-200 employees
Revolutionizing solid tumor treatment through AI-powered protein engineering. OUTSMART™, OUTLAST™, and OUTSPACER™ technologies enhance…
LabGenius51-200 employees
LabGenius Therapeutics is pioneering a closed-loop platform that combines AI, robotic automation, and synthetic biology to accelerate the…

Overview

TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.